Thyrotropin alfa
Thyrogen (thyrotropin alfa) is a protein pharmaceutical. Thyrotropin alfa was first approved as Thyrogen on 1998-11-30. It is used to treat thyroid neoplasms in the USA. It has been approved in Europe to treat thyroid neoplasms. The pharmaceutical is active against thyrotropin receptor.
| Trade Name | Thyrogen |
|---|---|
| Common Name | Thyrotropin alfa |
| Indication | thyroid neoplasms |
| Drug Class | Tricyclic compounds; atropine derivatives |
